Trends in the incidence of non-melanoma skin cancer in Slovakia, 1978-1995

被引:0
|
作者
Plesko, I [1 ]
Severi, G
Obsitníková, A
Boyle, P
机构
[1] Natl Canc Inst, Natl Canc Registry, Bratislava 83310, Slovakia
[2] Slovak Acad Sci, Canc Res Inst, Dept Epidemiol, Bratislava, Slovakia
[3] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy
关键词
skin cancers; non-melanoma; epidemiology; incidence; time trends;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-melanoma skin cancer (NMSC) incidence in Slovakia in the period 1978-1995 was analyzed. A total of 38 629 microscopically confirmed NMSC cases (19 600 in males and 19 029 in females) were registered by the National Cancer Registry: 31 714 (82.1%)were basal cell carcinomas (BCC), 6396 (16.6%) squamous cell carcinomas (SCC) and only 519 (1.3%) other NMSC. Age-standardized rates of NMSC increased in the given period by 59.1% in males and 58.5% in females. The greatest increase was observed for BCC, 70.4% and 65.0% in mares and females respectively, the smaller for SCC, 13.5 and 18.8%. In the period 1993-1995 age-standardized incidence rates per 100 000 were 38.0 for BCC, 6.7 for SCC and 45.5 for all NMSC in males and 29.2, 3.8 and 33.6, respectively in females. The observed marked increase of incidence with age was particularly pronounced for SCC. In both sexes, head and neck was the most common localization of BCC and SCC (84.2 to 74.7%), followed by trunk for BCC (17.0% in males and 10.8% in females) and by upper limbs for SCC (with 11.6% in males and 12.5% in females). Very fast increase of BCC incidence over time, its slower increase with age as compared to SCC incidence and body-site distribution suggest that BCC etiology is much more similar to melanoma etiology than SCC one. Registration of NMSC in relation to changes in possible risk factors (i.e. sun exposure/protection, ozone layer decrease) is important to study the mechanism of disease occurrence and to support public health interventions.
引用
收藏
页码:137 / 142
页数:6
相关论文
共 50 条
  • [31] MicroRNA in non-melanoma skin cancer
    Sand, Michael
    Sand, Daniel
    Altmeyer, Peter
    Bechara, Falk G.
    [J]. CANCER BIOMARKERS, 2012, 11 (06) : 253 - 257
  • [32] The management of non-melanoma skin cancer
    Campbell, FA
    Gupta, G
    [J]. HOSPITAL MEDICINE, 2005, 66 (05): : 288 - 293
  • [33] Risk of subsequent non-melanoma skin cancers in patients with prior non-melanoma skin cancer
    Wehner, M. R.
    Linos, E.
    Parvataneni, R.
    Stuart, S. E.
    Boscardin, W. J.
    Chren, M.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S93 - S93
  • [34] NON-MELANOMA SKIN-CANCER
    MORA, RG
    [J]. PRIMARY CARE, 1989, 16 (03): : 665 - 684
  • [35] NON-MELANOMA SKIN-CANCER
    DUVIVIER, A
    [J]. PRACTITIONER, 1984, 228 (1392) : 549 - 553
  • [36] Immunotherapy for Non-melanoma Skin Cancer
    Sophia Z. Shalhout
    Kevin S. Emerick
    Howard L. Kaufman
    David M. Miller
    [J]. Current Oncology Reports, 2021, 23
  • [37] Non-Melanoma Skin Cancer - Overview
    Joseph, Kurian
    [J]. CURRENT CANCER THERAPY REVIEWS, 2016, 12 (03) : 142 - 151
  • [38] Photoimmunology of non-melanoma skin cancer
    Streilein, JW
    [J]. CANCER SURVEYS, 1996, 26 : 207 - 217
  • [39] Non-melanoma skin cancer in Australia
    Fransen, Marloes
    Karahallos, Amalia
    Sharma, Niyati
    English, Dallas R.
    Giles, Graham G.
    Sinclair, Rodney D.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2012, 197 (10) : 565 - 568
  • [40] Cetuximab in non-melanoma skin cancer
    Wollina, Uwe
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (07) : 949 - 956